The feasibility of using an 'opt-out' approach to achieve universal HIV testing of tuberculosis patients in Alberta

Canadian Journal of Public Health

Volumn 100, Issue 2, 2009, Pages 116-120

  Sturtevant, Doris ^a   Preiksaitis, Jutta ^b   Singh, Ameeta ^c   Houston, Stan ^a   Gill, John ^d   Predy, Gerry ^e   Fisher, Dina ^d   Senthilselvan, Ambikaipakan ^a   Manfreda, Jure ^f   Boffa, Jody ^a   Long, Richard ^a,c,g  

^a UNIVERSITY OF ALBERTA   (Canada)

^b PROVINCIAL LABORATORY FOR PUBLIC HEALTH   (Canada)

^c Provincial Health Office   (Canada)

^d UNIVERSITY OF CALGARY   (Canada)

^e Capital Health Edmonton   (Canada)

^f UNIVERSITY OF MANITOBA   (Canada)

^g Aberhart Hospital   (Canada)

Author keywords

HIV; Tuberculosis

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADOLESCENT; ADULT; CANADA; CHILD; COMPARATIVE STUDY; COMPLICATION; CONFIDENCE INTERVAL; FACTUAL DATABASE; FEASIBILITY STUDY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV INFECTIONS; HUMAN; INFANT; MALE; MASS SCREENING; MIDDLE AGED; NEWBORN; PATIENT ATTITUDE; PRESCHOOL CHILD; REGISTER; RISK; RISK FACTOR; SERODIAGNOSIS; STANDARDS; STATISTICAL MODEL; TUBERCULOSIS, PULMONARY; UTILIZATION; YOUNG ADULT;

ADOLESCENT; ADULT; AIDS SERODIAGNOSIS; ALBERTA; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHILD; CHILD, PRESCHOOL; CONFIDENCE INTERVALS; DATABASES, FACTUAL; FEASIBILITY STUDIES; FEMALE; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; LOGISTIC MODELS; MALE; MASS SCREENING; MIDDLE AGED; ODDS RATIO; PATIENT ACCEPTANCE OF HEALTH CARE; REGISTRIES; RISK FACTORS; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 64949200611     PISSN: 00084263     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03405519     Document Type: Article

References (30)

1. th Ed. Ottawa, ON: Canadian Lung Association/ Public Health Agency of Canada, 2007. Available online at: http://www.phacaspc.gc.ca/tbpc-latb/pubs/tbstand07-eng.php (Accessed February 12, 2009).
2. Guelar A, Gatell JM, Verdejo J, Podzamczer D, Lozano L, Aznar E, et al. A prospective study of the risk of tuberculosis among HIV-infected patients. AIDS 1993;7:1345-49.
3. Antonucci G, Girardi E, Raviglione MC, Ippolito G, et al. for the GISTA. Risk factors for tuberculosis among HIV-infected persons. A prospective cohort study. JAMA 1995;274:143-48.
4. Wood R, Maartens G, Lombard CJ. Risk factors for developing tuberculosis in HIV-1-infected adults from communities with low or very high incidence of tuberculosis. J Acquir Immune Defic Syndr 2000;23:75-80.
5. Selwyn PA, Hartel D, Lewis VA, Schoenbaum EE, Vermund SH, Klein RS, et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. New Engl J Med 1989,320:54550.
6. Centers for Disease Control and Prevention. Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: Principles of therapy and revised recommendations. MMWR Recomm Rep 1998;47(RR-20):1-51.
7. The Canadian Tuberculosis Committee of the Centre for Infectious Disease Prevention and Control, Population and Public Health Branch, Health Canada. Recommendations for screening and prevention of tuberculosis in patients with HIV and for screening for HIV in patients with tuberculosis and their contacts. CCDR 2002;28(ACS-7):l-6.
8. McCarthy BD, Wong JB, Munoz A, Sonnenberg FA. Who should be screened for HIV infection? A cost-effectiveness analysis. Arch Intern Med 1993;153:1107-16.
9. Centers for Disease Control and Prevention. Tuberculosis and immunodeficiency virus infection: Recommendations of the Advisory Committee for the Elimination of Tuberculosis (ACET). MMWR 1989;38(14):236-38, 243-50.
10. Canadian Thoracic Society, Tuberculosis Directors of Canada, Department of National Health and Welfare in consultation with the provincial and territorial epidemiologists, AIDS coordinators and HIV caregivers. Guidelines for the identification, investigation and treatment of individuals with concomitant tuberculosis and HIV infection. CCDR 1992;18:155-60.
11. Harris T, Panaro L, Phypers M, Choudhri Y, Archibald CP. HIV testing among Canadian tuberculosis cases from 1997 to 1998. Can J Infect Dis Med Microbiol 2006;17:165-68.
12. Tuberculosis in Canada 2003. Ottawa: Public Health Agency of Canada. Available online at: http://www.phac-aspc.gc.ca/tbpc-latb/surv-eng.php (Accessed February 12, 2009).
13. Expert Working Group on HIV Testing. Counselling Guidelines for HIV Testing. Ottawa: Canadian Medical Association, 1995.
14. Frieden T, Das-Douglas M, Kellerman S, Henning K. Applying public health principles to the HIV epidemic. New Engl J Med 2005;353:239 7-402.
15. Bayer R, Fairchild AL. Changing the paradigm for HIV testing - the end of exceptlonalism. N Engl J Med 2006;355:647-49.
16. Joint United Nations Programme on HIV/AIDS (UNAIDS)/World Health Organization (WHO). UN/AIDS/WHO policy statement on HIV testing. Available online at: http://www.who.int/hiv/pub/vct/statement/en/ (Accessed February 12, 2009).
17. Canadian International Development Agency. Available online at: http://www.acdi-cida.gc.ca/index-e.htm (Accessed February 12, 2009).
18. Public Health Agency of Canada. HIV/AIDS Epi Updates, November 2007. Ottawa: Surveillance and Risk Assessment Division, Centre for Infectious Disease Prevention and Control, Public Health Agency of Canada, 2007.
19. Horsburgh C, Feldman S, Ridzon R. Practice guidelines for the treatment of tuberculosis. CID 2000;31:633-39.
20. Blenkush MF, Korzeniewska-kozela M, Elwood RK, Black W, Fitzgerald JM. HIV-related tuberculosis in British Columbia: Indications of a rise in prevalence and a change in risk groups. Clin Invest Med 1996;19:271-78.
21. Geduld J, Brassard P, Culman K, Tannenbaum TN. Testing for HIV among patients with tuberculosis in Montreal. Clin Invest Med 1999;22:111-18.
22. World Health Organization (WHO). Global tuberculosis control: Surveillance, planning, and financing. WHO Report 2006. Geneva: WHO, 2006. Available online at: http://www.who.int/tb/pubications/global-report/en/ (Accessed February 12, 2009).
23. Cowie RL, Sharpe JW. Extrapulmonary tuberculosis: A high frequency in the absence of HIV infection. Int J Tuberc Lung Dis 1997;1:159-62.
24. Korzeniewska-kosela M, FitzGerald JM, Vedal S, Allen EA, Schechter MT, Lawson L, et al. Spectrum of tuberculosis in patients with HIV infection in British Columbia: Report of 40 cases. CMAJ 1992;146:1927-34.
25. Brassard P, Remis RS. Incidence of tuberculosis among reported AIDS cases in Quebec from 1979 to 1996. CMAJ 1999,160:1838-42.
26. Public Health Agency of Canada. HIV and AIDS in Canada. Surveillance Report to June 30, 2006. Ottawa: Surveillance and Risk Assessment Division, Centre for Infectious Disease Prevention and Control, Public Health Agency of Canada, 2006.
27. Plitt S, Singh A, Lee B, Preiksaitis J. HIV seroprevalence among women opting out of prenatal HIV screening in Alberta, Canada: 2002-2004. CID 2007;45:1640-43.
28. Royce R, Walter E, Fernandez I, Wilson T, Ickovics J, Simonds R for the Perinatal Guidelines Evaluation Project. Barriers to universal prenatal HIV testing in 4 US locations in 1997. Am J Public Health 2001;91:727-33.
29. Jayaraman G, Preiksaitis J, Larke B. Mandatory reporting of HIV infection and opt-out prenatal screening for HIV infection: Effect on testing rates. CMAJ 2003;168:679-82.
30. Wang F-L, Larke B, Gabos S, Hanrahan A, Schopflocher D. Potential factors that may affect acceptance of routine prenatal HIV testing. Can J Public Health 2005;96(l):60-64.